2型糖尿病的治疗概况
罗丽敏;
摘要(Abstract)：
<正>糖尿病(DM)是一类高发病率的慢性疾病,且发病率有逐年增加的趋势,已成为危害人类健康的重大疾病。而且糖尿病及其并发症已成为继癌症和心
关键词(KeyWords)：
基金项目(Foundation):
作者(Authors):
罗丽敏;
参考文献(References)：
- [1]孔强,崔囯敏.胰岛素抵抗的治疗[J].临床荟萃,1999,14(2):86.
- [2]Pensenghm G,Price TB,Petersen KF,et al.Increased glucose trans-port-phophorglation and muscle glucogen synthesis after exercise training in insulin-resistance sub-jects.N Eng J M,1996,335:1357-1362.
- [3]张强.浅谈2型糖尿病早期治疗的联合用药[J].中华实用医药杂志,2004,4(18):52.
- [4]伍少伟,张晓莉,冯慧芳,等.2型糖尿病强化治疗五年观察[J].辽宁实用糖尿病杂志,2004,12(1):18.
- [5]余叶蓉,索丽霞.2型糖尿病的诊治与胰岛素抵抗[J].辽宁实用糖尿病杂志,2002,10(1):2-5.
- [6]王玉霞,方华.349例2型糖尿病并发症临床分析[J].实用临床医学,2006,7(6):57.
- [7]U.K Prospective Diabetes Study Group.Intensive bloodglucose co-nvetional treatment and risk of complications in patients with type2diabetes(VKPDS33).Lancet,1999,352:837-853.
- [8]李光伟.纠正肥胖与胰岛素抵抗对2型糖尿病防治的重要性[J].中国糖尿病杂志,2003,11(2):77.
- [9]武晋晓,谷华娟.口服降糖药物的联合应用[J].实用糖尿病杂志,2006,2(3):54-55.
- [10]Garcia-Ocana A,Vasavada RC,Cebrian A,et al.Transgenic over-expression of hepatocyte growth factor in the β-cell markedly improves islet function and islet transplant out-comes in mice.Diabetes,2001,502752-2762.
- [11]卢斌.糖尿病基因治疗的研究进展[J].国外医学内分泌学分册,2004,24:49.
- [12]Slosberg ED,Desai UT,Fanelli B,et al.Treatment of type 2 diab-etes by adenoviral-mediated ove-rexpression of the glucokinase reg-ulatory protein.Diabetes,2001,50:1813-1820.
- [13]Murphy JE,Zhou S,Giese K,et al.Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virusencoding mouse lep-tin.Proc Natl Acad Sci USA,1997,94:13921-13926.
- [14]Emanueli C,Salis MB,Pinna A,et al.Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer.Circulation,2002,106:993-999.
- [15]Goss JR,Goins WF,Lacomis D,et al.Herpessimplex-mediated gene transfer of nerve growth factor protectsagainst peripheral neur-opathy in streptozotocin-induced diabetes in the mouse.Diabetes,2002,51:2227-2232.